Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Antimicrobial Therapeutic Drug Monitoring in Critically Ill Patients
2019-004947-65Phase 4Active
- Sponsor
- Santiago Grau Cerrato
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of linezolid and meropenem in Airways Infection, Intra-abdominal infection (IAI) and bacterial disease (2 arms), sponsored by Santiago Grau Cerrato. Primary endpoint: Clinical response. Started Sep 2021; status: active.
02
Drugs
linezolidmeropenem
03
Conditions
Airways InfectionIntra-abdominal infection (IAI)bacterial disease
Beyond the preview
Go deeper on 2019-004947-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004947-65.